$4.22
-0.14-3.21%
At Close: -
$4.16
-0.06-1.42%
After Hours: 7:46 PM EDT
15 minutes delayed
Zentalis Pharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Zentalis Pharma using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-09 | $-1.24 | $-0.84 | -47.6 % |
Mar 2024 | 2024-05-07 | $0.14 | $-0.77 | 118.2 % |
Dec 2023 | 2024-02-27 | $-0.83 | $-0.92 | 9.78 % |
Sep 2023 | 2023-11-06 | $-0.79 | $-0.91 | 13.2 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-05-07 | $40.56M | $13.12M | 209.1 % |
Zentalis Pharma (ZNTL) is scheduled to report earnings on November 4, 2024. The last reported earnings were for reported on August 9, 2024 for Q2.
The Actual EPS was $-1.24, which missed the estimate of $-0.84.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.